Molecular mechanism of preconditioning

Area of Science:

• Cardiovascular Physiology
• Molecular Cardiology
• Cellular Adaptation

Background:

• Ischemic preconditioning (PC) is a potent endogenous mechanism protecting against ischemia-reperfusion injury.
• Knowledge of PC has grown significantly since its initial discovery.
• PC is the most effective known strategy for limiting infarct size.

Purpose of the Study:

• To review the signaling molecules involved in regulating cardiomyocyte life and death during ischemia and reperfusion.
• To elucidate the biphasic nature and molecular underpinnings of ischemic preconditioning.

Main Methods:

• Review of existing literature on ischemic preconditioning.
• Analysis of molecular pathways activated during early and late preconditioning.
• Focus on signaling molecules regulating cardiomyocyte survival.

Main Results:

• PC exhibits a biphasic pattern: early (2-3 hours) and late (24-96 hours).
• Early PC is more potent in reducing infarct size, mediated by adenosine, opioids, and protein kinases.
• Late PC attenuates myocardial stunning, requiring genomic activation and de novo protein synthesis (e.g., iNOS, COX-2).

Conclusions:

• Ischemic preconditioning involves complex signaling cascades impacting cardiomyocyte survival.
• Distinct molecular mechanisms underlie early and late preconditioning.
• Further research is needed to fully clarify the final mechanisms of PC.